181 related articles for article (PubMed ID: 36362766)
1. Bone Metastases of Diverse Primary Origin Frequently Express the VDR (Vitamin D Receptor) and CYP24A1.
Seiler J; Ebert R; Rudert M; Herrmann M; Leich E; Weißenberger M; Horas K
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362766
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
3. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
4. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.
Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B
J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of a Novel Vitamin D
Alshabrawy AK; Cui Y; Sylvester C; Yang D; Petito ES; Barratt KR; Sawyer RK; Heatlie JK; Polara R; Sykes MJ; Atkins GJ; Hickey SM; Wiese MD; Stringer AM; Liu Z; Anderson PH
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883516
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
8. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer.
Voutsadakis IA
Mol Biol Rep; 2020 Dec; 47(12):9821-9830. PubMed ID: 33259013
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1,25 and 24,25 Vitamin D on Corneal Epithelial Proliferation, Migration and Vitamin D Metabolizing and Catabolizing Enzymes.
Lu X; Chen Z; Mylarapu N; Watsky MA
Sci Rep; 2017 Dec; 7(1):16951. PubMed ID: 29208972
[TBL] [Abstract][Full Text] [Related]
11. Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat.
Mandell E; Seedorf GJ; Ryan S; Gien J; Cramer SD; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L1018-26. PubMed ID: 26342089
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes.
Christofi C; Lamnis L; Stark A; Palm H; Römer K; Vogt T; Reichrath J
Anticancer Res; 2022 Oct; 42(10):5049-5067. PubMed ID: 36191995
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
15. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages.
Matsunawa M; Amano Y; Endo K; Uno S; Sakaki T; Yamada S; Makishima M
Toxicol Sci; 2009 May; 109(1):50-8. PubMed ID: 19244278
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1,25 and 24,25 Vitamin D on Corneal Fibroblast VDR and Vitamin D Metabolizing and Catabolizing Enzymes.
Lu X; Chen Z; Watsky MA
Curr Eye Res; 2021 Sep; 46(9):1271-1282. PubMed ID: 33535006
[No Abstract] [Full Text] [Related]
17. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
18. The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
Kim JS; Roberts JM; Bingman WE; Shao L; Wang J; Ittmann MM; Weigel NL
Endocrinology; 2014 Sep; 155(9):3262-73. PubMed ID: 24926821
[TBL] [Abstract][Full Text] [Related]
19. Expression of VDR and CYP24A1 mRNA in human tumors.
Anderson MG; Nakane M; Ruan X; Kroeger PE; Wu-Wong JR
Cancer Chemother Pharmacol; 2006 Jan; 57(2):234-40. PubMed ID: 16180015
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
